Free Trial

Mount Lucas Management LP Has $1.86 Million Stake in MetLife, Inc. (NYSE:MET)

MetLife logo with Finance background

Mount Lucas Management LP grew its stake in MetLife, Inc. (NYSE:MET - Free Report) by 93.2% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 23,140 shares of the financial services provider's stock after purchasing an additional 11,163 shares during the period. Mount Lucas Management LP's holdings in MetLife were worth $1,858,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently bought and sold shares of MET. Norges Bank bought a new position in shares of MetLife in the fourth quarter worth about $730,716,000. Price T Rowe Associates Inc. MD raised its stake in shares of MetLife by 33.7% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 24,663,239 shares of the financial services provider's stock worth $2,019,427,000 after acquiring an additional 6,213,923 shares during the last quarter. Clearbridge Investments LLC raised its stake in shares of MetLife by 43.7% in the fourth quarter. Clearbridge Investments LLC now owns 5,663,177 shares of the financial services provider's stock worth $463,701,000 after acquiring an additional 1,723,461 shares during the last quarter. Northern Trust Corp raised its stake in shares of MetLife by 15.7% in the fourth quarter. Northern Trust Corp now owns 7,052,202 shares of the financial services provider's stock worth $577,434,000 after acquiring an additional 958,458 shares during the last quarter. Finally, GAMMA Investing LLC raised its stake in shares of MetLife by 8,789.6% in the first quarter. GAMMA Investing LLC now owns 815,889 shares of the financial services provider's stock worth $65,508,000 after acquiring an additional 806,711 shares during the last quarter. 94.99% of the stock is currently owned by institutional investors and hedge funds.

MetLife Trading Up 1.6%

MET opened at $77.58 on Wednesday. The company's 50 day moving average is $78.96 and its 200-day moving average is $79.82. MetLife, Inc. has a 1-year low of $65.21 and a 1-year high of $89.05. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.55. The company has a market cap of $52.08 billion, a P/E ratio of 12.61, a PEG ratio of 0.62 and a beta of 0.85.

MetLife (NYSE:MET - Get Free Report) last posted its earnings results on Wednesday, April 30th. The financial services provider reported $1.96 EPS for the quarter, missing the consensus estimate of $2.00 by ($0.04). The business had revenue of $18.57 billion for the quarter, compared to analyst estimates of $18.06 billion. MetLife had a return on equity of 20.89% and a net margin of 6.08%. The firm's quarterly revenue was up 15.6% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.83 earnings per share. Equities research analysts predict that MetLife, Inc. will post 9.65 earnings per share for the current fiscal year.

MetLife announced that its board has initiated a stock buyback program on Wednesday, April 30th that permits the company to repurchase $3.00 billion in shares. This repurchase authorization permits the financial services provider to buy up to 5.9% of its stock through open market purchases. Stock repurchase programs are generally an indication that the company's board of directors believes its stock is undervalued.

MetLife Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 9th. Investors of record on Tuesday, August 5th will be given a dividend of $0.5675 per share. The ex-dividend date is Tuesday, August 5th. This represents a $2.27 dividend on an annualized basis and a dividend yield of 2.93%. MetLife's payout ratio is presently 36.91%.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on the stock. Wall Street Zen downgraded shares of MetLife from a "buy" rating to a "hold" rating in a research note on Saturday, May 24th. Keefe, Bruyette & Woods decreased their price objective on shares of MetLife from $95.00 to $94.00 and set an "outperform" rating for the company in a report on Wednesday, July 9th. UBS Group upped their price target on shares of MetLife from $94.00 to $98.00 and gave the company a "buy" rating in a report on Wednesday, April 2nd. Wells Fargo & Company reiterated an "overweight" rating and issued a $97.00 price target (up previously from $94.00) on shares of MetLife in a report on Thursday, July 10th. Finally, Piper Sandler upped their price target on shares of MetLife from $92.00 to $94.00 and gave the company an "overweight" rating in a report on Wednesday, April 2nd. Two investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $95.50.

View Our Latest Stock Analysis on MET

About MetLife

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

See Also

Institutional Ownership by Quarter for MetLife (NYSE:MET)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in MetLife Right Now?

Before you consider MetLife, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.

While MetLife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

AI Stocks Are Printing Money — These 3 Are Just Getting Started
Why Drone Stocks Are Skyrocketing Right Now!
Pelosi Makes Big Bet on Broadcom—Here’s Why It Matters

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines